Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2026-02-21 @ 10:11 PM
Study NCT ID:
NCT04542057
Status:
COMPLETED
Last Update Posted:
2023-10-16
First Post:
2020-09-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
Sponsor:
Verona Pharma plc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RPL554-CO-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |